Lenalidomid BMS 25 mg, Hartkapseln - 21 Swissmedic Key 68490007 CM Registration Holder Bristol-Myers Squibb SA Name Lenalidomid BMS 25 mg, Hartkapseln Date of registration 14.06.2021 Original/Generic Generic Introduction of Sequence 14.06.2021 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 21 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 861.14 Limitation Yes Limitation text
Deductible 10 % Consumer price 1005.95 Feedback FB Daily cost GTIN 7680684900075 Medication Code Synthetika Pharmacode Disponibility
Composition lenalidomidum 25 mg, lactosum 200 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.8 mg, magnesii stearas, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula. Packungsbestandteile Galenic Form Capsules Active Agent Dose Lenalidomidum 25 mg
BAG: Active Agent Dose Lenalidomidum 25 mg
Inactive agents Dose additional_information (Nigrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Gelatina Kapselhülle Kalii Hydroxidum Lacca Drucktinte Lactosum 200 mg Magnesii Stearas Pro Capsula Propylenglycol
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
